Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol vs. Metoclopramide for Acute Headache
NCT02972502Phase 4Terminated
- Sponsor
- OhioHealth
- Start
- Feb 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of haloperidol in Headache and migraine, sponsored by OhioHealth. Started Feb 2014; status: terminated.
02
Drugs
haloperidol
03
Conditions
Headachemigraine
Beyond the preview
Go deeper on NCT02972502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02972502.